Kovitz Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$723K Sell
23,611
-60
-0.3% -$1.89K 0.04% 91
2015
Q3
$705K Sell
23,671
-2,343
-9% -$75.1K 0.04% 74
2015
Q2
$828K Buy
26,014
+1,050
+4% +$34.2K 0.05% 74
2015
Q1
$824K Sell
24,964
-1,939
-7% -$61.6K 0.05% 75
2014
Q4
$795K Sell
26,903
-633
-2% -$18.1K 0.04% 81
2014
Q3
$773K Sell
27,536
-37
-0.1% -$1.04K 0.04% 75
2014
Q2
$776K Sell
27,573
-4,509
-14% -$129K 0.04% 75
2014
Q1
$878K Sell
32,082
-395
-1% -$11.8K 0.05% 73
2013
Q4
$944K Sell
32,477
-137
-0.4% -$3.99K 0.04% 74
2013
Q3
$889K Sell
32,614
-92
-0.3% -$2.5K 0.04% 75
2013
Q2
$869K Buy
+32,706
New +$904K 0.04% 75

Other funds holding PFE

Kovitz Investment Group's PFE Position: Q4 2015 in Review

Kovitz Investment Group reduced its Pfizer (PFE) stake by 0.25% in Q4 2015, selling an estimated $1.89K and leaving 23,611 shares worth $723K. The position accounts for 0.04% of the portfolio, ranked #91.

Kovitz Investment Group first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $944K in Q4 2013. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Kovitz Investment Group held 23,611 shares of Pfizer worth $723K as of Q4 2015.
  • Kovitz Investment Group sold 60 Pfizer shares in Q4 2015, an estimated $1.89K.
  • Pfizer made up 0.04% of Kovitz Investment Group's portfolio in Q4 2015, its #91 holding.
  • Kovitz Investment Group first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
  • Kovitz Investment Group's Pfizer position peaked at $944K in Q4 2013.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Kovitz Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.